Previous Article | Next Article ![]()
Infection and Immunity, May 2004, p. 2843-2849, Vol. 72, No. 5
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.5.2843-2849.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Cory D. Dunn,2 Helena Ong,1 Eleanor S. Metcalf,3 and Mark J. Soloski1*
Division of Molecular and Clinical Rheumatology, Department of Medicine,1 Department of Cell Biology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,2 Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 208143
Received 22 July 2003/ Returned for modification 28 October 2003/ Accepted 13 February 2004
|
|
|---|
|
|
|---|
Intracellular and extracellular bacterial pathogens can bind to and be internalized by professional antigen-presenting cells (APCs) (29). Many intracellular pathogens survive within host membrane-bound vesicles and, in some instances, replicate within these vesicles. Despite this subcellular localization, several examples have been described wherein bacterial antigens derived from intracellular bacteria gain access to the class I processing pathway for presentation by MHC class I to bacterium-specific CD8+ effector T cells (reviewed in reference 21).
The processing of bacterial antigens through the MHC class I pathway has been shown to be independent of bacterial cytoplasmic localization (47). Several models have been proposed to account for this phenomenon, including peptide regurgitation, leaky endosomal membranes, disruption of overloaded endosomes, and direct binding to cell surface class I molecules (reviewed in reference 40). However, none of these models to date has resulted in a general picture of the mechanism(s) by which endosomal antigens access the cytosol. More recently, it has been proposed that direct cytosolic transfer of selected Salmonella or Yersinia proteins occurs efficiently and is independent of host cell invasion (7). It is interesting that even noninvasive Escherichia coli strains can sensitize target cells to lysis by human bacterium-specific CTLs (24). Studies with salmonellae have shown that, once internalized, Salmonella organisms reside within a membrane-bound vacuolar compartment (4, 46). All of these observations indicate that multiple mechanisms likely exist by which a peptide(s) can be presented by class I molecules.
Previous studies have identified a Salmonella Hsp 60-derived epitope presented to CD8+ CTLs by the Qa-1 class Ib molecule (32). The presentation of this Hsp 60 epitope is both TAP and proteasome dependent. In the present study we investigated the processing and presentation pathway for the generation of Salmonella-derived Qa-1-restricted epitopes. Our results suggest the existence of a novel alternative class I antigen-processing pathway in which exogenous antigens can be processed through a cytosolic pathway under phagocytic stimuli provided by live Salmonella organisms. Considering the abundant nature of bacterial Hsp 60 and the upregulation of this protein upon infection of eukaryotic cells (5), this mode of antigen presentation may be relevant to a general understanding of the host defense against all gram-negative bacteria.
|
|
|---|
In experiments with heat-killed S. enterica serovar Typhimurium (HKST), log-phase bacteria were incubated in a 72°C water bath for 1 h and the viability was assessed by plating on LB plates. In selected experiments using opsonized heat-killed bacteria, heat-killed bacteria were exposed to 50% normal homologous mouse serum in Hanks' balanced salt solution (HBSS) for 30 min and were washed twice with HBSS before use.
Cell lines and in vitro infection of tissue culture cells. The J774 macrophage cell line, the A20 B-cell lymphoma cell line, and the EL4 T-cell lymphoma cell line were cultured in RPMI supplemented with 10% fetal calf serum (RPMI-10). Qa-1b-expressing variants of the class I-deficient murine melanoma cell line B78H1 and the L-cell fibroblast line generated by cotransfection of the plasmids pSG-37 and pSV-2neo have been described previously (27, 45). The Qa-1b-expressing B78Hi and L-cell lines were maintained in selection medium (DMEM-10 supplemented with G418 [Sigma Chemical, St. Louis, Mo.] at 600 µg/ml so as to maintain high levels of Qa-1b expression). Tissue culture cells (106) were coincubated with the bacteria at a multiplicity of infection (MOI) of 100 and were pelleted by centrifugation at 600 x g. The bacterial cell pellets were incubated at 37°C for 30 min and washed two times in medium, and the cell density was adjusted as appropriate. For CTL assays, all infected cells were incubated at 37°C for another 1 h to allow for antigen processing. The efficiency of infection was assessed 2 h after the last wash step by enumerating gentamicin-protected intracellular bacteria as described previously (34) and by staining bacteria with the Diff-quik stain set (Baxter Scientific, Edison, N.J.) per the manufacturer's instructions.
Cytotoxic T-cell assays. In experiments using cytochalasin D (Calbiochem, La Jolla, Calif.), J774 and P815 cells were pretreated with cytochalasin D at 50 µg/ml for 1 h at 37°C. Cells were then washed thoroughly with complete medium and were infected with S. enterica serovar Typhimurium C5 as described above. In experiments using chloroquine (Calbiochem), C5-infected P815 cells were incubated with 50 µM chloroquine for 1 h and then were washed before 51Cr labeling.
Infected and uninfected target cells (2 x 106/200 µl) were labeled with 51Cr for 1 h. Labeled cells were washed with prewarmed (37°C) medium, resuspended in 2 ml of T-cell medium (TCM) (32, 33), centrifuged through 1.5 ml of warm fetal calf serum, resuspended in 5 ml of TCM, and allowed to incubate at 37°C for 1 h. Suspensions of labeled cells were then spun through fetal calf serum again and were counted (37). The density of the labeled target cells was adjusted to 5 x 104/ml. One hundred microliters (5 x 103 cells) of the labeled targets was dispensed into each well of 96-well U-bottomed plates and was mixed with an equal volume of effector cells at the indicated effector:target ratios. After 4 h of incubation, 100 µl of the supernatant was harvested and the released 51Cr was counted. The percent specific lysis was calculated as 100% x (counts per million [cpm] of experimental release cpm of spontaneous release)/(cpm of total release in the presence of 1% Nonidet P-40 cpm of spontaneous release).
Detection of translocated bacterial proteins in S. enterica serovar Typhimurium-infected cells. A modification of the procedure developed by Collazo et al. (7) was utilized. Briefly, cultures of J774 cells were infected with S. enterica serovar Typhimurium strains at an MOI of 100 as described above. Following infection, cells were washed with HBSS and then were incubated for various periods of time in medium with 100 µg of gentamicin/ml to kill extracellular bacteria. Cells were harvested and either mock treated or treated with 30 µg of proteinase K/ml in HBSS for 15 min at 37°C to eliminate cell surface-associated residual bacterial proteins. After proteinase K treatment, cells were washed and solubilized in 1% sodium dodecyl sulfate (SDS). Solubilized samples were sonicated on ice and centrifuged at 15,000 x g for 10 min; protein levels were determined by using the Bio-Rad protein assay, and the samples were adjusted to 2% 2-mercaptoethanol prior to gel electrophoresis. Approximately 106 cell equivalents were applied to each lane of the gel and were analyzed by SDS-10% polyacrylamide gel electrophoresis. Lysates prepared from uninfected control targets were run in parallel. SDS-polyacrylamide gels were then transferred to nitrocellular membranes and were probed with horseradish peroxidase-coupled polyclonal rabbit anti-GroEL (dilution, 1:2,000; Sigma Chemical). This reagent does not cross-react with the mammalian Hsp 60 molecule and cross-recognizes Salmonella GroEL (see Fig. 6).
![]() View larger version (70K): [in a new window] |
FIG. 6. Detection of Hsp 60 in Salmonella-infected cells. J774 cells were infected at an MOI of 100 followed by incubation in the presence of 0.1 mg of gentamicin/ml. At 0, 1, 2, and 3 h after infection, cells were harvested, resuspended with (+) or without () 30 µg of proteinase K (pk)/ml, and incubated for 15 min at 37°C. Following washing, cells were solubilized in SDS and the presence of bacterial Hsp 60 was detected by Western blotting with rabbit anti-Hsp 60. The arrow designates the Salmonella Hsp 60 species detected when cells were infected with strain SR11 (wild type, top panel) or invasion-deficient strain invA (middle panel) or invE (bottom panel). Extracts from uninfected cells (lane U) were analyzed in parallel. wt, wild type.
|
|
|
|---|
6%) overnight with HKST. To enhance the phagocytosis of bacteria by J774 cells, HKST were incubated with normal mouse serum for 30 min, after which they were used to pulse J774 cells (Fig. 1B). The results show that after opsonization, SalTc 1.69 was now able to recognize HKST-pulsed J774 targets, but the levels of CTL-mediated lysis was reduced in comparison with CTL-mediated lysis in response to live-bacterium-infected J774 cells (Fig. 1). In contrast to the results observed with the gram-positive bacterium L. monocytogenes, our results indicate that infection of target cells with viable bacteria rather than killed S. enterica serovar Typhimurium is significantly more effective for the initiation of class I processing of serovar Typhimurium-derived antigens.
![]() View larger version (22K): [in a new window] |
FIG. 1. The Salmonella-specific Qa-1b-restricted CTL clone SalTc 1.69 recognizes opsonized heat-killed bacteria. J774 macrophages were pulsed with HKST for 1 h (B) or overnight (A) or with HKST opsonized in normal mouse serum (NMS) (B) for 30 min. At the end of coincubation, J774 cells were labeled with 51Cr and used as targets in a CTL assay employing SalTc 1.69 as the effector at the indicated effector:target ratios. The viability of the bacteria was confirmed by plating an aliquot of the heat-killed bacteria on LB plates. For comparison, live C5-infected J774 cells were included in these assays.
|
![]() View larger version (24K): [in a new window] |
FIG. 2. SalTc 1.69 recognizes infected target cells of various lineages. EL-4 (A), A20 (B), B78Hi and B78Hi-Qa-1b (C), and J774 (D) cells were infected with S. enterica serovar Typhimurium C5 and tested for recognition by SalTc 1.69. (E) The average numbers of intracellular bacteria for J774, EL-4, A20, and B78Hi-Qa-1b were 3.2, 1.2, 1.5, and 2.5, respectively. The average number of viable bacteria, determined 2 h after infection, represents the mean taken from three separate samples each of 106 cells.
|
Previous studies demonstrated that SalTc 1.69 recognizes a peptide derived from the Salmonella Hsp 60 molecule (32). In the present study, we asked whether the Salmonella Hsp 60 protein can be detected in infected target cells. C5-infected J774, P815, and L-Qa-1b cells were lysed, and the lysates were probed with anti-Hsp 60 immune sera (7). The results are shown in Fig. 3 and indicate that Salmonella Hsp 60 was detected in infected cells but not in uninfected cells (Fig. 3B). In parallel, internalized bacteria were quantified by invasion assays as described above. Similar to the results shown in Fig. 2, P815 and L-Qa-1b were infected at a lower efficiency than J774 macrophages (Fig. 3A). More importantly, these experiments demonstrate that significant levels of Salmonella Hsp 60 are detected in infected target cells, despite the low level of internalized bacteria. Collectively, our results show that active uptake of bacteria by host cells does not correlate with susceptibility to CTL lysis.
![]() View larger version (25K): [in a new window] |
FIG. 3. Sensitization of target cells to CTL lysis does not correlate with bacterial invasion. (A) J774, P815, and L-Qa-1b cells infected with C5 were lysed with 1% Triton X-100 for quantification of intracellular bacteria 2 h following infection. The average number of viable bacteria, determined 2 h after infection, represents the mean of three separate samples, each of 106 cells. (B) Cellular lysates prepared from infected (C5) and uninfected () target cells were probed with immune sera against bacterial Hsp 60 as described in Materials and Methods.
|
![]() View larger version (26K): [in a new window] |
FIG. 4. Pretreatment of target cells with cytochalasin D does not affect bacterial Hsp 60 antigen processing. J774 (A) and P815 (B) cells were left untreated (squares) or exposed to cytochalasin D at 50 µg/ml (diamonds) for 1 h at 37°C. The cells were then washed and infected with C5. (C) The average number of viable bacteria, determined 2 h after C5 infection, represents the mean taken from three separate samples, each of 106 cells.
|
![]() View larger version (22K): [in a new window] |
FIG. 5. Susceptibility of infected target cells does not depend on the type III protein secretion system of S. enterica serovar Typhimurium. J774 (A) and P815 (B) cells were infected with parental strain SR11 (squares), the invA mutant (diamonds), or the invE mutant (circles), respectively. Infected target cells were tested for lysis by clone SalTc 1.69.
|
Based on the above-described studies that indicated that processing and presentation of the Salmonella Hsp 60 epitope does not require internalization of whole viable bacteria and yet is Tap and proteasome dependent, we hypothesized that the host was playing a major role in the internalization of Hsp 60. Therefore, we examined whether a novel endocytic process of the host that uses the organic base chloroquine, which blocks the release of endocytosed material, could be implicated. As shown in Fig. 7, target cells treated with chloroquine were no longer efficiently recognized by peptide-specific CTLs. These results indicate that the Salmonella Hsp 60 molecule that is processed and presented gains entry into the host cell by a chloroquine-dependent endocytic pathway.
![]() View larger version (21K): [in a new window] |
FIG. 7. Chloroquine interferes with CTL recognition. Salmonella-infected P815 cells were treated with 50 µM chloroquine (circle) or were mock treated (square) prior to labeling with 51Cr and testing for lysis by bulk Salmonella-specific CTLs derived from the spleen of infected BALB/c mice (left panel) or the Salmonella-specific CTL clone SalTc 1.69 (right panel). Control uninfected cells are also shown (triangle).
|
|
|
|---|
The observation that viable bacteria are required for the elicitation of target sensitivity implies that S. enterica serovar Typhimurium is an active participant in the process that permits the bacterial Hsp 60 protein to gain access to the class I processing pathway. It is well known that when Salmonella encounters an appropriate host cell surface, the bacterium initiates a series of events that leads to internalization and residency in membrane-bound vesicles. Therefore, it seemed reasonable that these internalized bacteria could be the source of antigen that is processed and presented. However, bacterial internalization did not appear to be required, because blocking internalization with cytochalasin D or the use of Salmonella isolates that are deficient in cell invasion failed to affect the processing and presentation of the Hsp 60-derived peptide. These data argue that extracellular bacteria are an important source of Hsp 60 antigen that eventually gains access to the cytoplasm for processing. This conclusion is supported by the observation that nonphagocytic cell types, which internalize bacteria inefficiently, are also efficiently recognized by CTLs.
Interestingly, under conditions that prevent cellular invasion, bacterial Hsp 60 proteins can be detected in the cytoplasm of infected cells. This observation indicates that Hsp 60 molecules derived from extracellular bacteria need to be translocated into the eukaryotic cell. Translocation of Hsp 60 does not involve the Salmonella SPI-1-encoded type III secretion system, because intracellular Hsp 60 can be easily detected after incubation of target cells with SPI-1-deficient Salmonella invA or invE mutants. This finding suggests that while viable extracellular bacteria are the source of antigen, bacteria are not mediating the translocation of Hsp 60 into the host cell via the type III secretion pathway.
The host cell appears to be largely responsible for Hsp 60 uptake, because chloroquine disrupts the eukaryotic endocytic pathway and blocks presentation of Hsp 60 in this case. The mechanism by which bacterial Hsp 60 is bound and internalized into an endocytic pathway is unclear. Several receptors have been reported for bacterial and mammalian Hsp 60 molecules, including Toll-like receptor-2 (TLR-2) and TLR-4 as well as a TLR-independent mechanism (6, 17, 35, 50). Studies examining the role of the cell surface protein OmpA on the gram-negative pathogen Klebsiella pneumoniae demonstrated that OmpA could bind to and signal cells in a TLR-2-dependent fashion (28). Furthermore, this binding leads to OmpA internalization and subsequent access to a TAP-dependent class I processing pathway. Therefore, it is reasonable to speculate that Salmonella-derived Hsp 60 binds to an Hsp 60 cell surface receptor(s) and initiates a signaling pathway leading to endocytosis and subsequent access to the MHC class I processing pathway.
The Hsp 60 protein is largely localized in the cytoplasm of bacteria, where it functions as a chaperone (1, 49). Also, Hsp 60 does not appear to be secreted or released from Salmonella organisms, because Hsp 60 is not detected in cell-free media from Salmonella cells grown under various growth conditions (C. D. Dunn and M. J. Soloski, unpublished data). However, Hsp 60 has been reported to be associated with the bacterial surfaces of Helicobacter pylori, Legionella pneumophila, and Clostridium difficile, and this may be a common feature of bacteria that bind to mammalian cell surfaces (23, 25, 52). In the case of L. pneumophila and C. difficile, a role in adherence and invasion has been proposed. Therefore, bacterial cell surface-associated proteins, or other forms of Hsp 60 expressed by Salmonella organisms, may become available for internalization upon binding to mammalian cell surfaces.
It remains unclear how Salmonella-derived antigens gain access to the cytosol for proteasome-dependent degradation, but bacterial Hsp 60 is clearly detected in infected target cells (Fig. 3B and 6). Salmonellae infect host cells and remain predominantly, if not exclusively, within a vacuolar endosomal compartment. S. enterica serovar Typhimurium can direct the translocation of bacterial proteins into host cells through a type III protein secretion system, and this process occurs with both intracellular and extracellular bacteria (7, 8). In our studies, however, invA and invE mutants, which have a defective type III secretion system, sensitize target cells to lysis to the same extent as the parental wild-type SR11 strain. These observations suggest that the SPI-1 type III secretion pathway of S. enterica serovar Typhimurium is not involved in the translocation of Hsp 60 into the cytoplasm for processing and presentation. While a type I (hemolysin-based) secretion system has been described for serovar Typhimurium (9, 11) and could function as a novel antigen delivery pathway, it is also possible that a host cell-based mechanism plays a role in the movement of antigen into the cytoplasm. In this regard, a class I processing pathway has been described where antigenic proteins localized to a vacuolar compartment are transported into the cytosol via a leakage mechanism where they intersect the MHC class I pathway (22, 30, 39, 48). This pathway, also referred to as cross-presentation, has been demonstrated to operate in professional APCs active in phagocytosis (22, 40, 44). Furthermore, recent studies have indicated that the translocation of vacuolar proteins into the cytosol may involve ER-associated elements, including the Sec61 retrotranslocation machinery, thereby providing a mechanism by which vacuole-associated proteins gain access to the proteosome (16, 26). Our observations suggest the presence of a vacuole-to-cytoplasm translocation pathway that is operative in both phagocytic and nonphagocytic cell types, because both are capable of presenting the Qa-1b-restricted Salmonella epitopes and the processing is TAP and proteosome dependent (32, 33).
Previous studies with Salmonella-expressed defined antigens showed that only professional phagocytes, such as macrophages, but not epithelial cells, are capable of processing and presenting Salmonella-carried antigens for the generation of class Ia-restricted T-cell epitopes (13, 18, 19). Taken together with our data, we would argue that while class Ia molecules present relevant bacterial antigens processed only by dendritic cells and macrophages, class Ib molecules, and Qa-1 in particular, may broadly present bacterial antigens processed by host cells of multiple lineages. Our findings make feasible the possibility that class Ib molecules expressed on nonphagocytic cells play a greater role in the generation of protective immunity than heretofore observed.
Present address: Department of Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan. ![]()
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»